2018-2023 Global Peptide Therapeutics Consumption Market Report

August 2018 | 166 pages | ID: 282973AD795EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Peptide Therapeutics market for 2018-2023.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
In this report, we study the peptide-based drugs.
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

Over the next five years, LPI(LP Information) projects that Peptide Therapeutics will register a 5.5% CAGR in terms of revenue, reach US$ 39300 million by 2023, from US$ 28500 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Injection
• Oral
• Other

Segmentation by application:

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• Shire
• AbbVie
• Ipsen
• Allergan
• Ferring
• Merck
• The Medicines
• Roche
• J & J

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Peptide Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
• Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL PEPTIDE THERAPEUTICS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peptide Therapeutics Consumption 2013-2023
  2.1.2 Peptide Therapeutics Consumption CAGR by Region
2.2 Peptide Therapeutics Segment by Type
  2.2.1 Injection
  2.2.2 Oral
  2.2.3 Other
2.3 Peptide Therapeutics Consumption by Type
  2.3.1 Global Peptide Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Peptide Therapeutics Sale Price by Type (2013-2018)
2.4 Peptide Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Metabolic Disorders
  2.4.3 Central Nervous System
  2.4.4 Other
2.5 Peptide Therapeutics Consumption by Application
  2.5.1 Global Peptide Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global Peptide Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global Peptide Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL PEPTIDE THERAPEUTICS BY PLAYERS

3.1 Global Peptide Therapeutics Sales Market Share by Players
  3.1.1 Global Peptide Therapeutics Sales by Players (2016-2018)
  3.1.2 Global Peptide Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Peptide Therapeutics Revenue Market Share by Players
  3.2.1 Global Peptide Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global Peptide Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Peptide Therapeutics Sale Price by Players
3.4 Global Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Peptide Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Peptide Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PEPTIDE THERAPEUTICS BY REGIONS

4.1 Peptide Therapeutics by Regions
  4.1.1 Global Peptide Therapeutics Consumption by Regions
  4.1.2 Global Peptide Therapeutics Value by Regions
4.2 Americas Peptide Therapeutics Consumption Growth
4.3 APAC Peptide Therapeutics Consumption Growth
4.4 Europe Peptide Therapeutics Consumption Growth
4.5 Middle East & Africa Peptide Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas Peptide Therapeutics Consumption by Countries
  5.1.1 Americas Peptide Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas Peptide Therapeutics Value by Countries (2013-2018)
5.2 Americas Peptide Therapeutics Consumption by Type
5.3 Americas Peptide Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Peptide Therapeutics Consumption by Countries
  6.1.1 APAC Peptide Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC Peptide Therapeutics Value by Countries (2013-2018)
6.2 APAC Peptide Therapeutics Consumption by Type
6.3 APAC Peptide Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Peptide Therapeutics by Countries
  7.1.1 Europe Peptide Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe Peptide Therapeutics Value by Countries (2013-2018)
7.2 Europe Peptide Therapeutics Consumption by Type
7.3 Europe Peptide Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peptide Therapeutics by Countries
  8.1.1 Middle East & Africa Peptide Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Peptide Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Peptide Therapeutics Consumption by Type
8.3 Middle East & Africa Peptide Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Peptide Therapeutics Distributors
10.3 Peptide Therapeutics Customer

11 GLOBAL PEPTIDE THERAPEUTICS MARKET FORECAST

11.1 Global Peptide Therapeutics Consumption Forecast (2018-2023)
11.2 Global Peptide Therapeutics Forecast by Regions
  11.2.1 Global Peptide Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global Peptide Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Peptide Therapeutics Forecast by Type
11.8 Global Peptide Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Sanofi
  12.1.1 Company Details
  12.1.2 Peptide Therapeutics Product Offered
  12.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Sanofi News
12.2 Teva
  12.2.1 Company Details
  12.2.2 Peptide Therapeutics Product Offered
  12.2.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Teva News
12.3 Novo Nordisk
  12.3.1 Company Details
  12.3.2 Peptide Therapeutics Product Offered
  12.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novo Nordisk News
12.4 Takeda
  12.4.1 Company Details
  12.4.2 Peptide Therapeutics Product Offered
  12.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Takeda News
12.5 Eli Lilly
  12.5.1 Company Details
  12.5.2 Peptide Therapeutics Product Offered
  12.5.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Eli Lilly News
12.6 AstraZeneca
  12.6.1 Company Details
  12.6.2 Peptide Therapeutics Product Offered
  12.6.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 AstraZeneca News
12.7 Novartis
  12.7.1 Company Details
  12.7.2 Peptide Therapeutics Product Offered
  12.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Novartis News
12.8 Shire
  12.8.1 Company Details
  12.8.2 Peptide Therapeutics Product Offered
  12.8.3 Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Shire News
12.9 AbbVie
  12.9.1 Company Details
  12.9.2 Peptide Therapeutics Product Offered
  12.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 AbbVie News
12.10 Ipsen
  12.10.1 Company Details
  12.10.2 Peptide Therapeutics Product Offered
  12.10.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Ipsen News
12.11 Allergan
12.12 Ferring
12.13 Merck
12.14 The Medicines
12.15 Roche
12.16 J & J

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Product Specifications of Peptide Therapeutics
Figure Peptide Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Peptide Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Peptide Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Peptide Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Injection
Table Major Players of Injection
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Peptide Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Peptide Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Peptide Therapeutics Value Market Share by Type (2013-2018)
Table Global Peptide Therapeutics Sale Price by Type (2013-2018)
Figure Peptide Therapeutics Consumed in Cancer
Figure Global Peptide Therapeutics Market: Cancer (2013-2018) (K Units)
Figure Global Peptide Therapeutics Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure Peptide Therapeutics Consumed in Metabolic Disorders
Figure Global Peptide Therapeutics Market: Metabolic Disorders (2013-2018) (K Units)
Figure Global Peptide Therapeutics Market: Metabolic Disorders (2013-2018) ($ Millions)
Figure Global Metabolic Disorders YoY Growth ($ Millions)
Figure Peptide Therapeutics Consumed in Central Nervous System
Figure Global Peptide Therapeutics Market: Central Nervous System (2013-2018) (K Units)
Figure Global Peptide Therapeutics Market: Central Nervous System (2013-2018) ($ Millions)
Figure Global Central Nervous System YoY Growth ($ Millions)
Figure Peptide Therapeutics Consumed in Other
Figure Global Peptide Therapeutics Market: Other (2013-2018) (K Units)
Figure Global Peptide Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Peptide Therapeutics Value by Application (2013-2018)
Table Global Peptide Therapeutics Value Market Share by Application (2013-2018)
Figure Global Peptide Therapeutics Value Market Share by Application (2013-2018)
Table Global Peptide Therapeutics Sale Price by Application (2013-2018)
Table Global Peptide Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Peptide Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Peptide Therapeutics Sales Market Share by Players in 2016
Figure Global Peptide Therapeutics Sales Market Share by Players in 2017
Table Global Peptide Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Peptide Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Peptide Therapeutics Revenue Market Share by Players in 2016
Figure Global Peptide Therapeutics Revenue Market Share by Players in 2017
Table Global Peptide Therapeutics Sale Price by Players (2016-2018)
Figure Global Peptide Therapeutics Sale Price by Players in 2017
Table Global Peptide Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Peptide Therapeutics Products Offered
Table Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Peptide Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Peptide Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Peptide Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Peptide Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Peptide Therapeutics Value Market Share by Regions 2013-2018
Figure Global Peptide Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Peptide Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Peptide Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Peptide Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Peptide Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Peptide Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Peptide Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Peptide Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Peptide Therapeutics Value 2013-2018 ($ Millions)
Table Americas Peptide Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Peptide Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Peptide Therapeutics Consumption Market Share by Countries in 2017
Table Americas Peptide Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Peptide Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Peptide Therapeutics Value Market Share by Countries in 2017
Table Americas Peptide Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Peptide Therapeutics Consumption Market Share by Type in 2017
Table Americas Peptide Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Peptide Therapeutics Consumption Market Share by Application in 2017
Figure United States Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Peptide Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Peptide Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Peptide Therapeutics Consumption Market Share by Countries in 2017
Table APAC Peptide Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Peptide Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Peptide Therapeutics Value Market Share by Countries in 2017
Table APAC Peptide Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Peptide Therapeutics Consumption Market Share by Type in 2017
Table APAC Peptide Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Peptide Therapeutics Consumption Market Share by Application in 2017
Figure China Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Peptide Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Peptide Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Peptide Therapeutics Consumption Market Share by Countries in 2017
Table Europe Peptide Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Peptide Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Peptide Therapeutics Value Market Share by Countries in 2017
Table Europe Peptide Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Peptide Therapeutics Consumption Market Share by Type in 2017
Table Europe Peptide Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Peptide Therapeutics Consumption Market Share by Application in 2017
Figure Germany Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Peptide Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Peptide Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Peptide Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Peptide Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Peptide Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Peptide Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Peptide Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Peptide Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Peptide Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Peptide Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Peptide Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Peptide Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Peptide Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Peptide Therapeutics Value Growth 2013-2018 ($ Millions)
Table Peptide Therapeutics Distributors List
Table Peptide Therapeutics Customer List
Figure Global Peptide Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Peptide Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Peptide Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Peptide Therapeutics Consumption Market Forecast by Regions
Table Global Peptide Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Peptide Therapeutics Value Market Share Forecast by Regions
Figure Americas Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure United States Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure United States Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure China Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure China Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure India Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure India Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure France Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure France Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure UK Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure UK Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Peptide Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Peptide Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Peptide Therapeutics Value 2018-2023 ($ Millions)
Table Global Peptide Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Peptide Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Peptide Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Peptide Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Peptide Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Peptide Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Peptide Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Peptide Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Peptide Therapeutics Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Peptide Therapeutics Market Share (2016-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novo Nordisk Peptide Therapeutics Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Peptide Therapeutics Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Peptide Therapeutics Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Peptide Therapeutics Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Peptide Therapeutics Market Share (2016-2018)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shire Peptide Therapeutics Market Share (2016-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Peptide Therapeutics Market Share (2016-2018)
Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ipsen Peptide Therapeutics Market Share (2016-2018)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table The Medicines Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table J & J Basic Information, Manufacturing Base, Sales Area and Its Competitors